<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.2" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMABHR</journal-id>
<journal-title-group><journal-title>International Journal of Medical and All Body Health Research</journal-title><abbrev-journal-title>IJMABHR</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2582-8940</issn>
<publisher><publisher-name>Anfo Publication House</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">224</article-id>
<title-group><article-title>Analytical method development and validation for the quantitative analysis of Ibrutinib in API form and marketed pharmaceutical dosage form by using RP-HPLC</article-title></title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Vishwanath</surname><given-names>D</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>Sarkar</surname><given-names>Pobitra</given-names></name><xref ref-type="aff" rid="aff2"/></contrib>
<contrib contrib-type="author"><name><surname>Islam</surname><given-names>Aktarul</given-names></name><xref ref-type="aff" rid="aff2"/></contrib>
<contrib contrib-type="author"><name><surname>Salmankhan</surname></name><xref ref-type="aff" rid="aff2"/></contrib>
<contrib contrib-type="author"><name><surname>Sarkar</surname><given-names>Siddhartha</given-names></name><xref ref-type="aff" rid="aff2"/></contrib>
<aff id="aff1"><label>1</label>Assistant Professor, Department of Pharmaceutics, Sree Dattha Institute of Pharmacy, Sheriguda(V), Ibrahimpatnam(M) Ranga Reddy, Telangana, India</aff>
<aff id="aff2"><label>2</label>Department of Pharmaceutical Analysis, Sree Dattha Institute of Pharmacy, Sagar Road, Sheriguda, Ibrahimpatnam, Telangana, India</aff>
</contrib-group>
<pub-date publication-format="electronic" date-type="pub"><year>2024</year></pub-date>
<volume>5</volume>
<issue>1</issue>
<fpage>31</fpage>
<lpage>37</lpage>
<history>
<date date-type="received"><day>02</day><month>01</month><year>2024</year></date>
<date date-type="accepted"><day>05</day><month>02</month><year>2024</year></date>
</history>
<permissions><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/?utm"><license-p>CC BY-NC-SA 4.0</license-p></license></permissions>
<self-uri xlink:href="https://www.allmedicaljournal.com/article/224/analytical-method-development-and-validation-for-the-quantitative-analysis-of-ibrutinib-in-api-form"/>
<self-uri content-type="pdf" xlink:href="https://www.allmedicaljournal.com/article/224/download"/>
<abstract><p>A simple, rapid, specific and accurate reverse phase high performance liquid chromatographic method has been developed for the validated of Ibrutinib in bulk as well as in marketed pharmaceutical dosage form. This separation was performed on a Symmetry ODS C18 (4.6×250mm, 5µm) column with Methanol: Phosphate Buffer (35:65) v/v as mobile phase at a flow rate of 1.0 mL min−1 with UV detection at 235 nm; the constant column temperature was Ambient. The runtime under these chromatographic conditions was less than 8 min. The retention time of Ibrutinib was found to be 2.276min. The calibration plot was linear over the concentration range of 6–14 μg mL−1 with limits of detection and quantification values of 1.2 and 3.6 ng mL−1 respectively. The mean % assay of marketed formulation was found to be 99.86%, and % recovery was observed in the range of 98-102%. Relative standard deviation for the precision study was found</p></abstract>
<kwd-group kwd-group-type="author"><kwd>Ibrutinib</kwd><kwd>RP-HPLC</kwd><kwd>Validation</kwd><kwd>Accuracy</kwd><kwd>Precision</kwd><kwd>ICH Guidelines</kwd></kwd-group>
</article-meta>
</front>
<back><ref-list><title>References</title>
<ref id="R1"><label>1</label><mixed-citation>https://go.drugbank.com/drugs/DB09053</mixed-citation></ref>
<ref id="R2"><label>2</label><mixed-citation>https://pubchem.ncbi.nlm.nih.gov/compound/Ibrutinib</mixed-citation></ref>
<ref id="R3"><label>3</label><mixed-citation>https://en.wikipedia.org/wiki/Ibrutinib</mixed-citation></ref>
<ref id="R4"><label>4</label><mixed-citation>Weston A, Brown PR. HPLC: Principle and Practice. 1st ed. San Diego: Academic Press; 1997. p. 24-37.</mixed-citation></ref>
<ref id="R5"><label>5</label><mixed-citation>Kazakevich Y, Lobrutto R. HPLC for Pharmaceutical Scientists. 1st ed. Hoboken: Wiley-Interscience; 2007. p. 15-23.</mixed-citation></ref>
<ref id="R6"><label>6</label><mixed-citation>Kealey D, Haines PJ. Analytical Chemistry. 1st ed. Oxford: BIOS Scientific Publishers; 2002. p. 1-7.</mixed-citation></ref>
<ref id="R7"><label>7</label><mixed-citation>Braithwaite A, Smith FJ. Chromatographic Methods. 5th ed. Dordrecht: Kluwer Academic Publishers; 1996. p. 1-2.</mixed-citation></ref>
<ref id="R8"><label>8</label><mixed-citation>Chromatography. Available from: http://en.wikipedia.org/wiki/Chromatography</mixed-citation></ref>
<ref id="R9"><label>9</label><mixed-citation>Meyer VR. Practical High-Performance Liquid Chromatography. 4th ed. Chichester: John Wiley &amp; Sons Ltd; 2004. p. 7-8.</mixed-citation></ref>
<ref id="R10"><label>10</label><mixed-citation>Sahajwalla CG. A New Drug Development. Vol. 141. New York: Marcel Dekker Inc.; 2004. p. 421-6.</mixed-citation></ref>
<ref id="R11"><label>11</label><mixed-citation>Introduction to Column. Available from: http://amitpatel745.topcities.com/index_files/study/colu mn%20care.pdf</mixed-citation></ref>
<ref id="R12"><label>12</label><mixed-citation>Detectors used in HPLC. Available from: http://wiki.answers.com/Q/What_detectors_are_used_in _HPLC</mixed-citation></ref>
<ref id="R13"><label>13</label><mixed-citation>Detectors. Available from: http://hplc.chem.shu.edu/NEW/HPLC_Book/Detectors/det_uvda.html</mixed-citation></ref>
<ref id="R14"><label>14</label><mixed-citation>Detectors. Available from: http://www.dionex.com/enus/webdocs/64842-31644-02_PDA-100.pdf</mixed-citation></ref>
<ref id="R15"><label>15</label><mixed-citation>Detectors. Available from: https://www.ncbi.nlm.nih.gov/pubmed/8867705</mixed-citation></ref>
<ref id="R16"><label>16</label><mixed-citation>Detectors. Available from: http://www.chem.agilent.com/Library/applications/596 43559.pdf</mixed-citation></ref>
<ref id="R17"><label>17</label><mixed-citation>Detectors. Available from: http://hplc.chem.shu.edu/new/hplcbook/detector</mixed-citation></ref>
<ref id="R18"><label>18</label><mixed-citation>International Conference on Harmonisation (ICH). Draft ICH guidelines on validation of analytical procedures: Definitions and terminology. Federal Register. 1995;60:1126.</mixed-citation></ref>
<ref id="R19"><label>19</label><mixed-citation>ICH Harmonised Tripartite Guideline. Validation of analytical procedures: Methodology (Q2B). Geneva, Switzerland; 1996. p. 1-8.</mixed-citation></ref>
<ref id="R20"><label>20</label><mixed-citation>Introduction to analytical method validation. Available from: http://www.standardbase.hu/tech/HPLC%20validation %20PE.pdf</mixed-citation></ref>
<ref id="R21"><label>21</label><mixed-citation>Data elements required for assay validation [Internet]. Available from: http://www.labcompliance.com/tutorial/methods/default .aspx</mixed-citation></ref>
<ref id="R22"><label>22</label><mixed-citation>Snyder LR. Practical HPLC Method Development. 2nd ed. New York: John Wiley &amp; Sons; 1997. p. 180-2.</mixed-citation></ref>
<ref id="R23"><label>23</label><mixed-citation>Skoog DA, West DM, Holler FJ. Introduction to Analytical Chemistry. Philadelphia: Saunders College Publishing; 1994. p. 1-5.</mixed-citation></ref>
<ref id="R24"><label>24</label><mixed-citation>Sharma BK. Instrumental Method of Chemical Analysis. Meerut: Goel Publishing House; 1999. p. 175-203.</mixed-citation></ref>
<ref id="R25"><label>25</label><mixed-citation>Breaux J, Jones K. Understanding and implementing efficient analytical method development and validation. Journal of Pharmaceutical Technology. 2003;5:110-4.</mixed-citation></ref>
<ref id="R26"><label>26</label><mixed-citation>Willard HH, Merritt LL, Dean JA, Settle FA. Instrumental Methods of Analysis. 7th ed. New Delhi: CBS Publishers and Distributors; 1991. p. 436-9.</mixed-citation></ref>
<ref id="R27"><label>27</label><mixed-citation>ICH Q2A. Validation of analytical methods: Definitions and terminology. ICH Harmonised Tripartite Guideline; c1999.</mixed-citation></ref>
<ref id="R28"><label>28</label><mixed-citation>Illendula S, Priyanka D, Shirisha V, Rao KNV, Dutt R. A new simple method development and validation of ibrutinib in bulk and pharmaceutical dosage form by RP-HPLC. International Journal of Pharmacy and Biological Sciences – IJPBSTM. 2019;9(1):36-46.</mixed-citation></ref>
<ref id="R29"><label>29</label><mixed-citation>Kapavarapu S, Golkonda R, Chintala R. Validation of stability indicating RP-HPLC method for the assay of ibrutinib in pharmaceutical dosage form. Analytical Chemistry: An Indian Journal. 2016;16(1):7-19.</mixed-citation></ref>
<ref id="R30"><label>30</label><mixed-citation>Uppala V, Divya N, Charishma E, Harshavardan K, Shyamala M. Validated stability-indicating RP-HPLC method for determination of ibrutinib. Indo American Journal of Pharmaceutical Sciences. 2016;3(4):324-30.</mixed-citation></ref>
<ref id="R31"><label>31</label><mixed-citation>Mehta L, Naved T, Grover P, Bhardwaj M, Mukherjee D. Development and validation of novel and highly sensitive stability-indicating reverse phase ultra-performance liquid chromatography method for quantification of ibrutinib and its ten degradation products. Indian Journal of Pharmaceutical Sciences. 2020;82(6):958–66. International Journal of Medical and All Body Health Research www.allmedicaljournal.com Copyright and License © 2026 The Author(s). Authors retain the copyright of their published articles. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution Non Commercial-Share A like 4.0 International (CC BY-NC-SA 4.0) License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.</mixed-citation></ref>
</ref-list></back>
</article>